Supplemental Financial Information (Tables)

12 Months Ended

Dec. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Disaggregation of Revenue

The following table presents revenue disaggregated by sales channel:

	2023	2022	2021
Distributors	7,195	7,261	6,325
Original Equipment Manufacturers and Electronic Manufacturing Services	5,963	5,775	4,587
Other	118	169	151
Total	13,276	13,205	11,063

Schedule of Grants recorded in Operating Income [Table Text Block]

The grants recorded in operating income are included in the following line items in the statement of operations:

	2023	2022
Cost of Revenue	5	3
Research & Development	116	83
Selling, General and Administrative	2	2
	123	88

Schedule of Grants related in BS

The classification of the grants' related assets and liabilities in the Company’s Consolidated Balance Sheets is as follows:

	2023	2022
Other current assets	95	57
Other non-current assets	71	57
Other current liabilities	25	15
Other non-current liabilities	4	4

Schedule of Depreciation, Amortization and Impairment

Depreciation and amortization, including impairment charges, are as follows:

	2023	2022	2021
Depreciation of property, plant and equipment	652	605	551
Amortization of internal use software	20	12	7
Amortization of other identified intangible assets (*)	434	633	704
	1,106	1,250	1,262

(*)    For the period ending December 31, 2021, the amount includes an impairment charge as a result of the discontinuation of an IPR&D project for an amount of $36 million.

Schedule of Other Income (Expense)

The following table presents the split of other income (expense):

	2023	2022	2021
Result from MSA and TSA arrangements	(11)	2	(2)
Other, net	(4)	1	2
Total	(15)	3	—

Schedule of Financial Income and Expense

	2023	2022	2021
Interest income	187	61	4
Interest expense	(438)	(427)	(369)
Net gain (loss) on extinguishment of debt	—	(18)	(22)
Total other financial income (expense)	(58)	(50)	(16)
Total	(309)	(434)	(403)

Marketable Securities

At December 31, 2023 and December 31, 2022, the total carrying value of investments in equity securities is summarized as follows:

	2023	2022
Marketable equity securities	12	9
Non-marketable equity securities	55	18
Equity-accounted investments	101	71
	168	98

Summary of Carrying Value of Investments in Equity-Accounted Investees

The total carrying value of investments in equity-accounted investees is summarized as follows:

	2023			2022
	Shareholding %		Amount	Shareholding %		Amount
SMART Growth Fund, L.P.	8.41	%	42	8.41	%	38
SigmaSense, LLC	10.64	%	33	—		—
Others	—		26	—		33
			101			71

Results Relating to Equity-Accounted Investees

Results related to equity-accounted investees at the end of each period were as follows:

	2023	2022	2021
Company’s share in income (loss)	(7)	4	(1)
Other results	—	(5)	(1)
	(7)	(1)	(2)

Other Current Liabilities

Other current liabilities at December 31, 2023 and December 31, 2022 consisted of the following:

	2023	2022
Accrued compensation and benefits	500	467
Customer programs	280	432
Income taxes payable	170	296
Dividend payable	261	219
Other	644	652
	1,855	2,066

Schedule of Error Corrections and Prior Period Adjustments

We have reclassified certain amounts related to customer programs previously presented in “Accounts payable” to “Other current liabilities” as of December 31, 2022 to conform to current period presentation as follows:

	2022
Accounts payable:
As reported	1,617
Reclassification - customer programs	(432)
Adjusted	1,185
Other current liabilities:
As reported	1,634
Reclassification - customer programs	432
Adjusted	2,066